Two Sigma Advisers’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,204
Closed -$1.26M 309
2025
Q4
$1.26M Buy
+13,204
New +$1.33M ﹤0.01% 1372
2021
Q1
Sell
-185,361
Closed -$15.1M 2566
2020
Q4
$15.1M Buy
185,361
+138,400
+295% +$13.6M 0.04% 421
2020
Q3
$3.25M Buy
+46,961
New +$3.37M 0.01% 925

Other funds holding BNTX

Two Sigma Advisers's BNTX Position: Q1 2026 in Review

Two Sigma Advisers sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 13,204 shares — an estimated $1.26M sold.

Two Sigma Advisers first reported a position in BNTX in Q3 2020 and held it in 3 quarters. The position peaked at $15.1M in Q4 2020. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Two Sigma Advisers reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 13,204 BioNTech shares in Q1 2026, an estimated $1.26M.
  • Two Sigma Advisers first reported a position in BioNTech in Q3 2020 and held it in 3 quarters.
  • Two Sigma Advisers's BioNTech position peaked at $15.1M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.